The clinical decision support systems (CDSs) for diabetes have improved significantly over the years. Multiple factors serve as driving forces for the uptake of CDSs. Newer technologies, initiatives, government mandates, and a competitive environment collectively facilitate advancement in diabetes care. This book chapter summarizes global CDSs development in recent years. Our review of the past few years’ publications on CDSs for diabetes shows that the United States is leading the world in technology development and clinical evidence generation. Developing countries worldwide are catching up in CDSs development and standards of patient care. Though most CDSs and published studies are on diabetes diagnosis, treatment, and management, a small portion of the research is devoted to prediabetes and type I diabetes. Increased efforts worldwide have been devoted to artificial intelligence and machine learning in diabetes care.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.